NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
TEVELLE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TEVELLE PHARMACEUTICALS
ST13
US500000090664001Class
5
Filing
90664001
Registration
7762629
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
05/08/2025
Trademark type
Word
Nice classes
5
Filing date
04/22/2021
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
05/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/10/2023
First use in commerce
02/10/2023
Drawing code
4
Owner type
01
Owner location
South Portland, ME
Examiner
MCCARTHY, JOSEPH
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. K. (pessoa física)
Representatives
Jennifer C. Debrow Taft Stettinius & Hollister LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for animal joint careskin careneurologic careautoimmune caredigestive tract care
Publications
History of USPTO decisions and trademark events.
55 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/26/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/26/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/26/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/25/2025
IUAF
USE AMENDMENT FILED
01/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/01/2024
EX5G
SOU EXTENSION 5 GRANTED
07/01/2024
EXT5
SOU EXTENSION 5 FILED
07/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/16/2024
EX4G
SOU EXTENSION 4 GRANTED
01/12/2024
EXT4
SOU EXTENSION 4 FILED
01/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/06/2023
EX3G
SOU EXTENSION 3 GRANTED
06/02/2023
EXT3
SOU EXTENSION 3 FILED
06/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2022
EX2G
SOU EXTENSION 2 GRANTED
12/15/2022
EXT2
SOU EXTENSION 2 FILED
12/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/23/2022
EX1G
SOU EXTENSION 1 GRANTED
06/21/2022
EXT1
SOU EXTENSION 1 FILED
06/21/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2022
ASDF
ASSIGNMENT CHANGE WITHDRAWN
05/18/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/18/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/18/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/18/2021
ALIE
ASSIGNED TO LIE
10/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/15/2021
PBER
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
10/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/14/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/14/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/14/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2021
GNRT
NON-FINAL ACTION E-MAILED
10/05/2021
CNRT
NON-FINAL ACTION WRITTEN
10/05/2021
DOCK
ASSIGNED TO EXAMINER
09/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2021
NWAP
NEW APPLICATION ENTERED
04/26/2021
Continuous trademark protection
Get notified about every new filing that threatens TEVELLE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.